On May 16, 2023, the U.S. Food and Drug Administration (FDA) approved spinal cord stimulation (SCS) devices from the pharmaceutical company Abbott to treat chronic back pain in people who have not had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback